You just read:

Orexigen Therapeutics Announces Commercialization and Distributorship Agreement with Laboratorios Farmacéuticos Rovi, S.A. for Mysimba® (naltrexone HCl / bupropion HCl prolonged release) in Spain

News provided by

Orexigen Therapeutics, Inc.

Aug 01, 2016, 08:30 ET